Vinmec Institute of Stem Cell and Gene Technology, Vinmec Healthcare System, 458 Minh Khai, Hanoi 100000, Vietnam.
Center of Applied Science, Regenerative Medicine, and Advance Technologies (CARA), Vinmec Healthcare System, 458 Minh Khai, Hanoi 100000, Vietnam.
Int J Mol Sci. 2023 Feb 21;24(5):4284. doi: 10.3390/ijms24054284.
(1) Background: The dysfunction and reduced proliferation of peripheral CD8 T cells and natural killer (NK) cells have been observed in both aging and cancer patients, thereby challenging the adoption of immune cell therapy in these subjects. In this study, we evaluated the growth of these lymphocytes in elderly cancer patients and the correlation of peripheral blood (PB) indices to their expansion. (2) Method: This retrospective study included 15 lung cancer patients who underwent autologous NK cell and CD8 T cell therapy between January 2016 and December 2019 and 10 healthy individuals. (3) Results: On average, CD8 T lymphocytes and NK cells were able to be expanded about 500 times from the PB of elderly lung cancer subjects. Particularly, 95% of the expanded NK cells highly expressed the CD56 marker. The expansion of CD8 T cells was inversely associated with the CD4:CD8 ratio and the frequency of PB-CD4 T cells in PB. Likewise, the expansion of NK cells was inversely correlated with the frequency of PB-lymphocytes and the number of PB-CD8 T cells. The growth of CD8 T cells and NK cells was also inversely correlated with the percentage and number of PB-NK cells. (4) Conclusion: PB indices are intrinsically tied to immune cell health and could be leveraged to determine CD8 T and NK cell proliferation capacity for immune therapies in lung cancer patients.
(1) 背景:外周血 CD8 T 细胞和自然杀伤 (NK) 细胞的功能障碍和增殖减少在衰老和癌症患者中均有观察到,这使得免疫细胞疗法在这些患者中的应用受到挑战。在这项研究中,我们评估了老年癌症患者这些淋巴细胞的生长情况,并将外周血 (PB) 指标与它们的扩增相关联。(2) 方法:这项回顾性研究纳入了 2016 年 1 月至 2019 年 12 月期间接受自体 NK 细胞和 CD8 T 细胞治疗的 15 例肺癌患者和 10 例健康个体。(3) 结果:平均而言,来自老年肺癌患者 PB 的 CD8 T 淋巴细胞和 NK 细胞能够扩增约 500 倍。特别地,扩增的 NK 细胞中 95%高度表达 CD56 标志物。CD8 T 细胞的扩增与 CD4:CD8 比值和 PB-CD4 T 细胞的频率呈负相关。同样,NK 细胞的扩增与 PB-淋巴细胞的频率和 PB-CD8 T 细胞的数量呈负相关。CD8 T 细胞和 NK 细胞的生长也与 PB-NK 细胞的百分比和数量呈负相关。(4) 结论:PB 指标与免疫细胞健康密切相关,可以用来确定肺癌患者免疫治疗中 CD8 T 和 NK 细胞的增殖能力。